Cariprazine is a leading atypical antipsychotic medication produced by INTAS Pharmaceuticals, designed for the management of schizophrenia and bipolar I disorder, including episodes of mania, mixed states, or depression. This capsule-based medication functions by interacting with dopamine and serotonin receptors in the brain, contributing to mood stabilization, the reduction of hallucinations, and enhanced cognitive abilities. Cariprazine is available under the brand names Carnia, in strengths of 1.5mg, 3mg, and 4.5mg, and Carilift, which is available in a 6mg strength. It is essential to take this medication exactly as prescribed by a healthcare provider, with regular check-ups to monitor its efficacy and any adverse effects. Usage is not advised for elderly patients suffering from dementia-related psychosis, and the medicine may cause side effects such as fatigue, dizziness, or alterations in weight. It should be stored in a cool, dry location, shielded from direct sunlight and moisture, and kept out of children's reach.